Further meta-analysis involving previous and current studies in Chinese populations supported the findings of the current study, which suggests the effect of GNPDA2 on type 2 diabetes risk may be mediated through obesity. Here, GNPDA2 is linked to obesity due to melanocortin 4 receptor deficiency.